Surprisingly, the combination of EZH2-92aa inhibition, NK cell injection, and the anti-PD1 antibody fully maximized survival and even cleared the tumour masses in two mice from the treated group, showing a better effect than the combined treatment with EZH2-92aa inhibition plus NK cells (Fig. 7g). Here, EZH2 is linked to neoplasm.